321 related articles for article (PubMed ID: 8031148)
21. Neutrophil Proteases Activate Eosinophil Function in vitro.
Hiraguchi Y; Nagao M; Hosoki K; Tokuda R; Fujisawa T
Int Arch Allergy Immunol; 2008; 146 Suppl 1():16-21. PubMed ID: 18504401
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-2 activates human peripheral blood eosinophils.
Hoenstein R; Admon D; Solomon A; Norris A; Moqbel R; Levi-Schaffer F
Cell Immunol; 2001 Jun; 210(2):116-24. PubMed ID: 11520078
[TBL] [Abstract][Full Text] [Related]
23. A chymotrypsin-type serine protease in rat basophilic leukemia cells: evidence for its immunologic identity with atypical mast cell protease.
Kido H; Izumi K; Otsuka H; Fukusen N; Kato Y; Katunuma N
J Immunol; 1986 Feb; 136(3):1061-5. PubMed ID: 2416825
[TBL] [Abstract][Full Text] [Related]
24. Reaction of mast cell proteases tryptase and chymase with protease activated receptors (PARs) on keratinocytes and fibroblasts.
Schechter NM; Brass LF; Lavker RM; Jensen PJ
J Cell Physiol; 1998 Aug; 176(2):365-73. PubMed ID: 9648924
[TBL] [Abstract][Full Text] [Related]
25. The T cell-specific serine proteinase TSP-1 is associated with cytoplasmic granules of cytolytic T lymphocytes.
Fruth U; Prester M; Golecki JR; Hengartner H; Simon HG; Kramer MD; Simon MM
Eur J Immunol; 1987 May; 17(5):613-21. PubMed ID: 3556195
[TBL] [Abstract][Full Text] [Related]
26. Human mast cell chymase induces the accumulation of neutrophils, eosinophils and other inflammatory cells in vivo.
He S; Walls AF
Br J Pharmacol; 1998 Dec; 125(7):1491-500. PubMed ID: 9884078
[TBL] [Abstract][Full Text] [Related]
27. Rat serosal mast cell degranulation mediated by chymase, an endogenous secretory granule protease: active site-dependent initiation at 1 degree C.
Schick B; Austen KF
J Immunol; 1986 May; 136(10):3812-8. PubMed ID: 2939135
[TBL] [Abstract][Full Text] [Related]
28. Tryptase and chymase: comparison of extraction and release in two dog mastocytoma lines.
Caughey GH; Lazarus SC; Viro NF; Gold WM; Nadel JA
Immunology; 1988 Feb; 63(2):339-44. PubMed ID: 3127330
[TBL] [Abstract][Full Text] [Related]
29. Human eosinophil peroxidase: purification and characterization.
Carlson MG; Peterson CG; Venge P
J Immunol; 1985 Mar; 134(3):1875-9. PubMed ID: 3918110
[TBL] [Abstract][Full Text] [Related]
30. Cleavage of a rat serosal mast cell membrane component during degranulation mediated by chymase, a secretory granule protease.
Schick B
Immunology; 1990 Mar; 69(3):423-8. PubMed ID: 2312165
[TBL] [Abstract][Full Text] [Related]
31. The induction of eosinophil peroxidase release: improved methods of measurement and stimulation.
Adamko DJ; Wu Y; Gleich GJ; Lacy P; Moqbel R
J Immunol Methods; 2004 Aug; 291(1-2):101-8. PubMed ID: 15345309
[TBL] [Abstract][Full Text] [Related]
32. Eosinophil granule proteins activate human heart mast cells.
Patella V; de Crescenzo G; Marinò I; Genovese A; Adt M; Gleich GJ; Marone G
J Immunol; 1996 Aug; 157(3):1219-25. PubMed ID: 8757629
[TBL] [Abstract][Full Text] [Related]
33. Airway function correlates with circulating eosinophil, but not mast cell, markers of inflammation in childhood asthma.
Rao R; Frederick JM; Enander I; Gregson RK; Warner JA; Warner JO
Clin Exp Allergy; 1996 Jul; 26(7):789-93. PubMed ID: 8842552
[TBL] [Abstract][Full Text] [Related]
34. Eosinophilic granuloma of the bone in Hand-Schüller-Christian disease: extensive in vivo eosinophil degranulation and subsequent binding of released eosinophil peroxidase (EPO) to other inflammatory cells.
Zabucchi G; Soranzo MR; Menegazzi R; Cattin L; Vecchio M; Lanza F; Patriarca P
J Pathol; 1991 Mar; 163(3):225-31. PubMed ID: 1707451
[TBL] [Abstract][Full Text] [Related]
35. Human leukocyte elastase and cathepsin G are specific inhibitors of C5a-dependent neutrophil enzyme release and chemotaxis.
Tralau T; Meyer-Hoffert U; Schröder JM; Wiedow O
Exp Dermatol; 2004 May; 13(5):316-25. PubMed ID: 15140022
[TBL] [Abstract][Full Text] [Related]
36. Binding of eosinophil peroxidase to mast cell granules with retention of peroxidatic activity.
Henderson WR; Jong EC; Klebanoff SJ
J Immunol; 1980 Mar; 124(3):1383-8. PubMed ID: 6987310
[TBL] [Abstract][Full Text] [Related]
37. Matrix localization of tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor (TFPI-2/MSPI) involves arginine-mediated ionic interactions with heparin and dermatan sulfate: heparin accelerates the activity of TFPI-2/MSPI toward plasmin.
Liu Y; Stack SM; Lakka SS; Khan AJ; Woodley DT; Rao JS; Rao CN
Arch Biochem Biophys; 1999 Oct; 370(1):112-8. PubMed ID: 10496984
[TBL] [Abstract][Full Text] [Related]
38. [Inhibitory effect of AS-35. a novel antiallergic drug, on chemical mediator release from human eosinophils].
Kawashima T; Nagaki S; Iwakaji A; Iwamoto I; Yoshida S; Tomioka H
Arerugi; 1994 Dec; 43(11):1326-30. PubMed ID: 7887808
[TBL] [Abstract][Full Text] [Related]
39. The 2.2 A crystal structure of human chymase in complex with succinyl-Ala-Ala-Pro-Phe-chloromethylketone: structural explanation for its dipeptidyl carboxypeptidase specificity.
Pereira PJ; Wang ZM; Rubin H; Huber R; Bode W; Schechter NM; Strobl S
J Mol Biol; 1999 Feb; 286(1):163-73. PubMed ID: 9931257
[TBL] [Abstract][Full Text] [Related]
40. Neutrophil myeloperoxidase is a potent and selective inhibitor of mast cell tryptase.
Cregar L; Elrod KC; Putnam D; Moore WR
Arch Biochem Biophys; 1999 Jun; 366(1):125-30. PubMed ID: 10334872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
